SG Americas Securities LLC Purchases 184,459 Shares of CME Group Inc. $CME

SG Americas Securities LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 345.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 237,898 shares of the financial services provider’s stock after purchasing an additional 184,459 shares during the quarter. SG Americas Securities LLC owned 0.07% of CME Group worth $64,965,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Empowered Funds LLC grew its holdings in shares of CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after acquiring an additional 1,037 shares in the last quarter. AlphaCore Capital LLC bought a new position in CME Group in the 2nd quarter valued at $84,000. American Century Companies Inc. increased its position in shares of CME Group by 16.8% during the 2nd quarter. American Century Companies Inc. now owns 65,704 shares of the financial services provider’s stock valued at $18,109,000 after purchasing an additional 9,463 shares during the last quarter. Coldstream Capital Management Inc. increased its position in shares of CME Group by 21.0% during the 2nd quarter. Coldstream Capital Management Inc. now owns 6,429 shares of the financial services provider’s stock valued at $1,772,000 after purchasing an additional 1,116 shares during the last quarter. Finally, Global Retirement Partners LLC bought a new stake in CME Group in the second quarter worth about $1,931,000. Institutional investors own 87.75% of the company’s stock.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: BMO partnership to offer tokenized cash: CME’s permissioned network on Google Cloud Universal Ledger will be used by Bank of Montreal to launch 24/7 tokenized cash services for institutional clients — a clear revenue-adjacent product win that reinforces CME’s role in institutional digital-asset plumbing and could expand fee streams over time. CME, Bank of Montreal Team Up to Launch Tokenized Cash Service
• Neutral Sentiment: Short‑interest data appears unreliable: multiple March filings claim a “large increase” in short interest but simultaneously report 0 shares short and NaN changes — likely a reporting/data error. This item is unlikely to be a genuine pressure point for the stock unless corrected filings show real short positions.
• Neutral Sentiment: Analyst/institional landscape is mixed: recent analyst coverage shows a range of price targets (median ~$307) and a mix of buy/overweight and at least one underweight. Institutional activity is mixed as well (some large adds and large trims), implying divergent views on near‑term upside. These factors support volatility but not a decisive directional catalyst. CME GROUP INC. ($CME) Chairman and CEO 2025 Pay Revealed
• Negative Sentiment: Notable insider selling disclosed: a recent filing summary shows multiple insiders (including senior execs) sold shares over the past year and an estimated CEO pay disclosure — insider selling can be perceived negatively by the market and may weigh on sentiment if viewed as profit‑taking. CME GROUP INC. ($CME) Chairman and CEO 2025 Pay Revealed

Insider Activity

In related news, Director Dennis Suskind sold 748 shares of the stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the transaction, the director owned 2,699 shares of the company’s stock, valued at approximately $809,700. This trade represents a 21.70% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the completion of the transaction, the director owned 43,007 shares in the company, valued at approximately $13,317,117.55. The trade was a 8.90% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 8,539 shares of company stock valued at $2,713,821. Insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on the company. UBS Group restated a “neutral” rating and issued a $310.00 target price on shares of CME Group in a research note on Friday, February 6th. Raymond James Financial cut their price objective on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Morgan Stanley boosted their price objective on shares of CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a research report on Thursday, February 5th. Finally, TD Cowen upped their price target on shares of CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $304.06.

CME Group Trading Down 1.3%

Shares of CME stock opened at $302.68 on Wednesday. The business has a 50-day moving average price of $301.60 and a two-hundred day moving average price of $281.16. CME Group Inc. has a 12-month low of $248.53 and a 12-month high of $329.16. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The firm has a market cap of $108.55 billion, a P/E ratio of 27.12, a price-to-earnings-growth ratio of 3.31 and a beta of 0.24.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company’s revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the company earned $2.52 EPS. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s payout ratio is 46.59%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.